APA (7th ed.) Citation

Beridze, M., Christensen, H., Dineen, R. A., Duley, L., Heptinstall, S., James, M., . . . Bath, P. M. (2015). Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: Rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388). Wiley.

Chicago Style (17th ed.) Citation

Beridze, M., et al. Safety and Efficacy of Intensive Vs. Guideline Antiplatelet Therapy in High-risk Patients with Recent Ischemic Stroke or Transient Ischemic Attack: Rationale and Design of the Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke (TARDIS) Trial (ISRCTN47823388). Wiley, 2015.

MLA (9th ed.) Citation

Beridze, M., et al. Safety and Efficacy of Intensive Vs. Guideline Antiplatelet Therapy in High-risk Patients with Recent Ischemic Stroke or Transient Ischemic Attack: Rationale and Design of the Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke (TARDIS) Trial (ISRCTN47823388). Wiley, 2015.